Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanced Kidney Cancer Conducted in India [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the safety and efficacy of nivolumab plus ipilimumab in untreated advanced renal cell carcinoma completed in India, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Kidney Neoplasms | Phase 4 | Status: COMPLETED | Results posted: 2025-07-11